Search Results - "Girolomoni, G."

Job: the prototypic dermatological patient. Comments on a painting by Marcello Fogolino by Girolomoni, G.

Get full text

Epidemiology of atopic dermatitis in adults: Results from an international survey by Barbarot, S., Auziere, S., Gadkari, A., Girolomoni, G., Puig, L., Simpson, E. L., Margolis, D. J., Bruin‐Weller, M., Eckert, L.

“…Background There are gaps in our knowledge of the prevalence of adult atopic dermatitis (AD). Objective To estimate the prevalence of AD in adults and by…”
Get full text

Classifying immunopathological responses in chronic inflammatory skin diseases by Girolomoni, G.

Get full text

Public perception of dermatology and dermatologists: a very relevant but untapped issue by Girolomoni, G.

Get full text

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I by Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., Czarnecka‐Operacz, M., Schäfer, T., Schmid‐Grendelmeier, P., Simon, D., Szalai, Z., Szepietowski, J.C., Taïeb, A., Torrelo, A., Werfel, T., Ring, J.

“…This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a…”
Get full text

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II by Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., Czarnecka‐Operacz, M., Schäfer, T., Schmid‐Grendelmeier, P., Simon, D., Szalai, Z., Szepietowski, J.C., Taïeb, A., Torrelo, A., Werfel, T., Ring, J.

“…This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a…”
Get full text

Psoriasis: rationale for targeting interleukin-17 by Girolomoni, G., Mrowietz, U., Paul, C.

“…Summary The exact pathogenesis of plaque psoriasis remains to be fully determined, but it is thought to depend on environmental and genetic factors that…”
Get full text

Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical update by Gisondi, P., PIaserico, S., Bordin, C., Alaibac, M., Girolomoni, G., Naldi, L.

“…On 11 March 2020, the World Health Organization (WHO) has declared the novel coronavirus disease (COVID‐19) a global pandemic, caused by the severe acute…”
Get full text

European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group by Alexander, H., Paller, A.S., Traidl‐Hoffmann, C., Beck, L.A., De Benedetto, A., Dhar, S., Girolomoni, G., Irvine, A.D., Spuls, P., Su, J., Thyssen, J.P., Vestergaard, C., Werfel, T., Wollenberg, A., Deleuran, M., Flohr, C.

“…Summary Patients with atopic dermatitis (AD) have an increased risk of bacterial skin infections, which cause significant morbidity and, if untreated, may…”
Get full text

The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis by Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J., Boehncke, W.H., Prinz, J.C.

“…Psoriasis is a chronic, immune‐mediated disease affecting more than 100 million people worldwide and up to 2.2% of the UK population. The aetiology of…”
Get full text

Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies by Bellinato, F., Gisondi, P., Mantovani, A., Girolomoni, G., Targher, G.

“…Purpose Chronic plaque psoriasis is associated with the presence of non-alcoholic fatty liver disease (NAFLD), but the magnitude of this association remains…”
Get full text

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2) by Paul, C., Cather, J., Gooderham, M., Poulin, Y., Mrowietz, U., Ferrandiz, C., Crowley, J., Hu, C., Stevens, R.M., Shah, K., Day, R.M., Girolomoni, G., Gottlieb, A.B.

“…Summary Background Apremilast, an oral phosphodiesterase 4 inhibitor, regulates immune responses associated with psoriasis. Objectives ESTEEM 2 evaluated the…”
Get full text

Upadacitinib in patients with resistant atopic dermatitis: a retrospective case‐series by Dal Bello, G., Schena, D., Girolomoni, G.

Get full text

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients by Marzano, A.V., Genovese, G., Casazza, G., Fierro, M.T., Dapavo, P., Crimi, N., Ferrucci, S., Pepe, P., Liberati, S., Pigatto, P.D., Offidani, A., Martina, E., Girolomoni, G., Rovaris, M., Foti, C., Stingeni, L., Cristaudo, A., Canonica, G.W., Nettis, E., Asero, R.

“…Background Chronic spontaneous urticaria (CSU) is defined as spontaneous occurrence of wheals and/or angioedema for ≥6 weeks. Omalizumab is a monoclonal…”
Get full text

Monkeypox virus infection: what dermatologist needs to know? by Bellinato, F., Gisondi, P., Girolomoni, G.

Get full text

A systematic review of treatments for pityriasis lichenoides by Bellinato, F., Maurelli, M., Gisondi, P., Girolomoni, G.

“…Pityriasis lichenoides (PL) represents a spectrum of inflammatory skin diseases comprising pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis…”
Get full text

Undertreatment in adult patients with moderate‐to‐severe atopic dermatitis and other chronic inflammatory skin diseases by Gisondi, P., Girolomoni, G.

“…Linked articles: C. Pascal et al. J Eur Acad Dermatol Venereol 2020; 34: 2339–2345. https://doi.org/10.1111/jdv.16329…”
Get full text

The multifaceted association between psoriasis and obesity by Gisondi, P., Girolomoni, G.

“…Linked Article: Snekvik et al. Br J Dermatol 2019; 180:94–99…”
Get full text